PO vs IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation (POvIV2)
PO Versus IV Antibiotics for the Treatment of Infected Nonunion of Fractures After Fixation
Sponsor: Major Extremity Trauma Research Consortium
Listed as NCT05699174, this PHASE3 trial focuses on Amputation and Antibiotic Side Effect and remains actively recruiting participants. Sponsored by Major Extremity Trauma Research Consortium, it has been updated 7 times since 2023, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE3
-
Sep 2025 — Feb 2026 [monthly]
Recruiting PHASE3
-
Jun 2025 — Sep 2025 [monthly]
Recruiting PHASE3
-
Sep 2024 — Jun 2025 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
▶ Show 2 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Feb 2023 — Apr 2024 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Major Extremity Trauma Research Consortium
- United States Department of Defense
For direct contact, visit the study record on ClinicalTrials.gov .